LEVANON LAB
PUBLICATIONS
2026
121. Rosenwasser Z, Cohen-Fultheim R, Shliefer O, Levanon EY*, Eisenberg E*
Genome Research, Mar 2026 doi: 10.1101/gr.280820.125
120. Rosenwasser Z, Cohen-Fultheim R, Levitt M*, Levanon EY*, Oren G*
ADAR-GPT: A continually fine-tuned language model for predicting A-to-I RNA editing sites
PNAS. January 9, 2026 doi.org/10.1073/pnas.
Inositol hexakisphosphate Functions as a Cofactor and Modulator of ADAR1 Activity
bioRxiv, doi.org/10.64898/2026.01.17.699700
2025
118. Shmuel-Eidelman M, Cohen-Fultheim R, Eisenberg E*, Levanon EY*
Off-target RNA editing hotspots caused by base editors
Molecular Therapy, doi: 10.1016/j.ymthe.2025.12.043
117. Cohen-Fultheim R*, Twersky I*, Krupkin H, Roth SH, Levanon EY*, Eisenberg E*
A Cytoplasmic Index for Quantifying Immune-Related A-to-I RNA Editing
bioRxiv, doi.org/10.64898/2025.12.03.692070
RNA editing deficiency models differential immunogenicity of pancreatic α- and β-cells
Molecular Metabolism, doi.org/10.1016/j.molmet.2025.102183
115. Akira A, Levanon EY*, Ben Aroya S
Methods Enzymol. 2025 Jan 10 doi: 10.1016/bs.mie.2024.11.026
114. Merdler-Rabinowicz R*, Dadush A, Patiyal S, Rajagopal PS, Daya GN, Ben-Aroya S, Schäffer AA, Eisenberg E, Ruppin E, Levanon EY
NAR cancer. 2025 May 6 doi: 10.1093/narcan/zcaf016
113. Ahmad S, Zou T, Hwang J, Zhao L, Wang X, Davydenko A, Buchumenski I, Zhuang P, Fishbein AR, Capcha-Rodriguez D, Orgel A, Levanon EY, Myong S, Chou J, Meyerson M & Hur S
PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration
Nature communication. 2025 April 8 doi: 10.1038/s41467-025-58433-x
112. D’Addabbo P, Cohen-Fultheim R*, Twersky I*, Fonzino A, Silvestris DA, Prakash A, Mazzacuva PL, Vizcaino JA, Green A, Sweeney B,
Yates A, Lussi Y, Luo J, Martin MJ, Eisenberg E, Levanon EY, Pesole G, Picardi E.
REDIportal: toward an integrated view of the A-to-I editing
Nucleic Acids Res . 2025 Jan 6 doi: 10.1093/nar/gkae1083
2024
Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA
Nature Biotechnology 2024 Jul 12. doi: 10.1038/s41587-024-02313-0
BioRxiv https://doi.org/10.1101/2024.05.01.592034
DNA and RNA base editors can correct the majority of pathogenic single nucleotide variants
NPJ Genom Med. 2024 Feb 26;9(1):16.
Mol Ther Nucleic Acids. 2024 Jan 30;35(1):102130.
107. Knebel UE, Peleg S, Dai C, Cohen-Fultheim R, Jonsson S, Poznyak K, Israeli M, Zamashanski L ,Glaser B, Levanon EY, Powers AC, Klochendler A, Dor Y.
Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes
Cell Metab . 2024 Jan 2;36(1):48-61.e6.
106. Levanon EY, Cohen-Fultheim R, Eisenberg E
In search of critical dsRNA targets of ADAR1
Trends Genet . 2023 Dec 29:S0168-9525(23)00261-5.
2023
105. Zambrano-Mila MS, Witzenberger M , Rosenwasser Z, Uzonyi A , Nir R, Ben-Aroya S, Levanon EY, Schwartz S
Dissecting the basis for differential substrate specificity of ADAR1 and ADAR2
Nature Communications 14,8212 (2023)
104. Astre G, Atlan T, Goshtchevsky U, Oron-Gottesman A, Smirnov M, Shapira K, Velan A, Deelen J, Levy T, Levanon EY, Harel I.
Dev Cell. 2023 Aug 7;58(15):1350-1364.e10
103. Merdler-Rabinowicz R*, Gorelik D*, Park J, Meydan C, Foox J, Karmon M, Roth HS, Cohen-Fultheim R, Shohat-Ophir G, Eisenberg E, Ruppin E, Mason CE, Levanon EY.
Elevated A-to-I RNA editing in COVID-19 infected individuals
NAR Genom Bioinform 2023 Oct 18;5(4):lqad092.
102. Mann T ,Kopel E ,Eisenberg E , Levanon EY
Increased A-to-I RNA editing in atherosclerosis and cardiomyopathies
PLoS Comput Biol . 2023 Apr 10;19(4):e1010923.
101. Jbara A, Lin K, Stossel C, Siegfried Z, Shqerat H, Amar-Schwartz A, Elyada E, Mogilevsky M, Raitses-Gurevich M, Jared JL, Yaron TM, Ovadia O, Jang GH, Danan-Gotthold M, Cantley LC, Levanon EY, Gallinger S, Krainer AR, Golan T, Karni R
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
100. Avram-Shperling A, Kopel E, Twersky I, Gabay O, Ben-David A, Karako-Lampert S,Rosenthal JC, Levanon EY, Eisenberg E, Ben-Aroya S
PLoS Genet . 2023 Mar 6;19(3):e1010661
99. Szymczak F*, Cohen-Fultheim R*, Thomaidou S*, Coomans de Brachène A,Castela A, Colli M, Marchetti P, Levanon EY,
Eizirik D, Zaldumbide A
ADAR1-dependent editing regulates human β cell transcriptome diversity during inflammation
Front Endocrinol (Lausanne). 2022; 13: 1058345
98. Karmon M*, Kopel E*, Barzilai A, Geva P, Eisenberg E, ELevanon EY, Greenberger S
J Invest Dermatol. 2022 Dec 9;S0022-202X(22)02837-8
2022
Landscape of adenosine-to-inosine RNA recoding across human tissues
Progress in Retinal and Eye Research 2022
2021
95. Buchumenski I, Roth SH, Kopel E, Katsman E, FeiglinA, Levanon EY*, Eisenberg E*
Global quantification exposes abundant low-level off-target activity by base editors
94. Gold A, Levanon EY*, Eisenberg E*
The New RNA-Editing Era – Ethical Considerations
93. Uzonyi A ,Nir R, Shliefer O, Stern-Ginossar N, Antebi Y, Stelzer Y, Levanon EY, Schwartz S
Deciphering the principles of the RNA editing code via large-scale systematic probing
Mol Cell.
92. Buchumenski I*, Karoline Holler K*, Appelbaum L, Eisenberg E, Junker JP*, Levanon EY*
Systematic identification of A-to-I RNA editing in zebrafish development and adult organs
Nucleic Acids Res. 2021 Apr 19
91. Warhaftig G, Mushka Sokolik C, Khermesh K, Lichtenstein Y, Barak M, Bareli T, Levanon EY, Yadid G
RNA editing of the 5-HT2C receptor in the central nucleus of the amygdala is involved in resilience behavior
2020
90. Tsivion-Visbord H*, Kopel E*, Feiglin A, Sofer T, Barzilay R, Ben-Zur T, Yaron O, Offen D*, Levanon EY*
Increased RNA editing in maternal immune activation model of neurodevelopmental disease
89. Barak M, Porath HT, Finkelstein G, Knisbacher BA, Buchumenski I, Roth SH, Levanon EY*, Eisenberg E*
Purifying selection of long dsRNA is the first line of defense against false activation of innate immunity
88. Schaffer AA*, Kopel E*,Hendel A, Picardi E, Levanon EY*,Eisenberg E*
The cell line A-to-I RNA editing catalogue
87. Gassner FJ, Zaborsky N, Buchumenski I, Levanon EY, Gatterbauer M, Schubert M, Stefanie Rauscher S, Hebenstreit D, Nadeu F, Campo E, Egle A, Greil R, Geisberger R.
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia
86. Hanan M, Alon Simchovitz A, Yayon N, Vaknine S, Cohen‐Fultheim R, Karmon M, Madrer N, Rohrlich TM, Maman M, Bennett ER, Greenberg DS, Meshorer E, Levanon EY, Soreq H, Kadener S
A Parkinson's disease CircRNA s Resource reveals a link between circSLC 8A1 and oxidative stress
85. Schaffer AA, Levanon EY
ALU A-to-I RNA Editing: Millions of Sites and Many Open Questions
Methods in Molecular Biology 2020
84. Cohen-Fultheim R, Levanon EY
Detection of A-to-I Hyper-edited RNA Sequences
Methods in Molecular Biology 2020
2019
83. Roth SH ,Levanon EY, Eisenberg E
Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity
82. Ishizuka JJ, Manguso RT, Cheruiyot CJ, Bi K, Panda A, Iracheta-Vellve A, Miller BC, Du PP,Yates KB, Dubrot J,Buchumenski I ,Comstock DE,Brown FD, Ayer A, Kohnle IC, Pope HW, Zimmer MD, Sen DR, Lane-Reticker SK, Robitschek EJ,Griffin GK, Collins NB,Long AH, Doench JG, Kozono D, Levanon EY, Haining WN.
Loss of the RNA editing enzyme ADAR1 in tumors improves response to immunotherapy and overcomes therapeutic resistance.
81. Denichenko P, Mogilevsky M, Cléry A, Welte T, Biran J, Shimshon O, Barnabas GD, Danan-Gotthold M, Kumar S, Yavin E, Levanon EY, Allain FH, Geiger T, Levkowitz G, Karni R.
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides.
80. Porath HT, Hazan E, Shpigler H, Cohen M, Band M, Ben-Shahar Y, Levanon EY, Eisenberg E, Bloch G.
RNA editing is abundant and correlates with task performance in a social bumblebee
79. Esposito A, Falace A, Wagner M, Gal M, Mei D, Conti V, Pisano T, Aprile D, Cerullo MS, De Fusco A,
Giovedì S, Seibt A, Magen D, Polster T, Eran A, Stenton SL, Fiorillo C, Ravid S, Mayatepek E, Hafner H, SWortmann S, Levanon EY, Marini C, Mandel H, Benfenati F, Distelmaier F, Fassio A, Guerrini R
Biallelic DMXL2 mutations impair autophagy and cause Ohtahara syndrome with progressive course
78. Dick A L.W, Khermesh K, Paul EE, Stamp F, Levanon EY, Chen A
Adenosine-to-Inosine RNA Editing Within Corticolimbic Brain Regions Is Regulated in Response to Chronic Social Defeat Stress in Mice.
77. Pinto Y, Levanon EY.
Computational approaches for detection and quantification of A-to-I RNA-editing.
2018
76. Gannon HS, Zou T, Kiessling MK, Gao GF, Cai D, Choi PS, Ivan AP, Buchumenski I, Berger AC, Goldstein JT, Cherniack AD, Vazquez F, Tsherniak A, Levanon EY, Hahn WC, Meyerson M.
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells.
75. Eisenberg E, Levanon EY.
A-to-I RNA editing - immune protector and transcriptome diversifier.
74. Jain M*, Mann TD*, Stulić M*, Rao SP, Kirsch A, Pullirsch D, Strobl X, Rath C, Reissig L, Moreth K, Klein-Rodewald T, Bekeredjian R,
Gailus-Durner V, Fuchs H, Hrabě de Angelis M, Pablik E, Cimatti L, Martin D, Zinnanti J, Graier WF, Sibilia M, Frank S, Levanon EY, Jantsch MF.
RNA editing of Filamin A pre‐mRNA regulates vascular contraction and diastolic blood pressure
73. Shay Ben-Aroya, Levanon EY.
A-to-I RNA Editing: An Overlooked Source of Cancer Mutations.
72. Roth SH*, Danan-Gotthold M*, Ben-Izhak M, Rechavi G, Cohen CJ, Louzoun Y, Levanon EY.
Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus.
71. Jacob-Hirsch J, Eyal E, Knisbacher BA, Roth J, Cesarkas K, Dor C, Farage-Barhom S, Kunik V, Simon AJ, Gal M, Yalon M, Moshitch-Moshkovitz S, Tearle R, Constantini S, Levanon EY, Amariglio N, Rechavi G.
Whole-genome sequencing reveals principles of brain retrotransposition in neurodevelopmental disorders.
70. Shallev L*, Kopel E*, Feiglin A, Leichner GS, Avni D, Sidi Y, Eisenberg E, Barzilai A, Levanon EY*, Greenberger S*
Decreased A-to-I RNA editing as a source of keratinocytes dsRNA in psoriasis.
69. Mangul S, Yang HT, Strauli N, Gruhl F, Porath HT, Hsieh K, Chen L, Daley T, Christenson S, Wesolowska-Andersen A, Spreafico R, Rios C, Eng C, Smith AD, Hernandez RD, Ophoff RA, Santana JR, Levanon EY, Woodruff PG, Burchard E, Seibold MA, Shifman S, Eskin E, Zaitlen N.
ROP: dumpster diving in RNA-sequencing to find the source of 1 trillion reads across diverse adult human tissues.
68. Pinto Y, Buchumenski I, Levanon EY, Eisenberg E.
Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets.
2017
67. Solomon O, Di Segni A, Cesarkas K, Porath HT, Marcu-Malina V, Mizrahi O, Stern-Ginossar N, Kol N, Farage-Barhom S, Glick-Saar E, Lerenthal Y, Levanon EY, Amariglio N, Unger R, Goldstein I, Eyal E, Rechavi G.
RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure.
66. Liscovitch-Brauer N, Alon S, Porath HT, Elstein B,Unger R, Ziv T, Admon A, Levanon EY, ,Rosenthal, JJC,* Eisenberg E*
Trade-off between Transcriptome Plasticity and Genome Evolution in Cephalopods
65. Danan-Gotthold M, Levanon EY.
Promoting RNA editing by ADAR attraction.
64. Levy O, Knisbacher BA, Levanon EY*, Havlin S*.
Integrating networks and comparative genomics reveals retroelement proliferation dynamics in hominid genomes.
63. Porath HT, Knisbacher BA, Eisenberg E*, Levanon EY*.
Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance.
62. Porath HT, Schaffer AA, Kaniewska P, Alon S, Eisenberg E, Rosenthal J, Levanon EY*, Levy O*.
A-to-I RNA Editing in the Earliest-Diverging Eumetazoan Phyla.
Molecular Biology and Evolution 2017
61. Buchumenski I, Bartok O, Ashwal-Fluss R, Pandey V, Porath HT, Levanon EY, Kadener S.
Dynamic hyper-editing underlies temperature adaptation in Drosophila.
60. Kipper S, Frolov L, Guy O, Pellach M, Glick Y, Malichi A, Knisbacher BA, Barbiro-Michaely E, Avrahami D, Yavets-Chen Y, Levanon EY, Gerber D.
Control and automation of multilayered integrated microfluidic device fabrication.
59. Gal-Mark N, Shallev L, Sweetat S, Barak M, Billy Li J, Levanon EY, Eisenberg E, Behar O.
Abnormalities in A-to-I RNA editing patterns in CNS injuries correlate with dynamic changes in cell type composition
2016
58. Danan-Gotthold M, Guyon C, Giraud M, Levanon EY*, Abramson J*
Extensive RNA editing and splicing increase immune self-representation diversity in medullary thymic epithelial cells.
57. Li K, Wang L, Knisbacher BA, Xy Q, Levanon EY, Frenkel-Morgenstern M, Tagore S, Fang X, Wang H, Bazak L, Buchumenski I, Zhao Y, Lövy M, Li X, Han L, Frenkel Z, Beiles A, Cao Y, Wang Z. Nevo E
Transcriptome, genetic editing and microRNA divergence substantiate sympatric speciation of blind mole rat, Spalax.
56. Pinto Y, Gabay O, Arbiza L, Sams AJ, Keinan A*, Levanon EY*:
Clustered mutations in hominid genome evolution are consistent with APOBEC3G enzymatic activity.
55. Knisbacher BA, Levanon EY:
DNA Editing of LTR Retrotransposons Reveals the Impact of APOBECs on Vertebrate Genomes.
Molecular Biology and Evolution 2016
54. Gal M, Khermesh K, Barak M, Lin M, Lahat H, Reznik Wolf H, Lin M, Pras E, Levanon EY:
Expanding preconception carrier screening for the Jewish population using high throughput microfluidics technology and next generation sequencing.
53. Sapoznik S, Bahar-Shany K, Brand H, Pinto Y, Gabay O, Glick-Saar E, Dor C, Zadok O, Barshack I, Zundelevich A, Gal-Yam EN, Yung Y, Hourvitz A, Korach J, Beiner M, Jacob J, Levanon EY, Barak M, Aviel-Ronen S, Levanon K:
Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis.
52. Gal M, Magen D, Zahran Y, Ravid S, Eran A, Khayat M, Gafni C, Levanon EY*, Mandel H*:
A novel homozygous splice site mutation in NALCN identified in siblings with cachexia, strabismus, severe intellectual disability, epilepsy and abnormal respiratory rhythm.
European Journal of Medical Genetics 2016
51. Khermesh K, D'Erchia AM, Barak M, Annese A, Wachtel C, Levanon EY, Picardi E, Eisenberg E
Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease.
50. Knisbacher BA, Gerber D, Levanon EY
DNA Editing by APOBECs: A Genomic Preserver and Transformer.
2015
49. Geula A, Moshitch-Moshkovitz S, Dominissini D, AlFatah Mansour A, Kol N, Salmon-Divon M, Hershkovitz V, Peer E, Mor N, Ben Haim MS, Eyal E, Yunger S, Pinto Y, Jaitin DA, Viukov S, Rais Y, Krupalnik V, Chomsky E, Zerbib M, Maza I, Rechavi Y, Massarwa R, Hanna S, Amit I, Levanon EY, Amariglio N, Stern-Ginossar N, Rechavi G, Hanna JH:
m6A mRNA Methylation Facilitates Adequate Resolution of Naïve Pluripotency Towards Lineage Priming.
48. Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Rodriguez M, Piechotta M, Levanon EY, Landthaler M, Dieterich C, Rajewsky N:
Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals.
47. Shamay-Ramot A, Khermesh K, Porath HT, Barak M, Pinto Y, Wachtel C, Zilberberg A, Lerer-Goldshtein T, Efroni S, Levanon EY, Appelbaum L.
Fmrp Interacts with Adar and Regulates RNA Editing, Synaptic Density and Locomotor Activity in Zebrafish.
46. Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, Eisenberg E*, Levanon EY*:
Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors.
45. Danan-Gotthold M, Golan-Gerstl R, Eisenberg E, Meir K, Karni R*, Levanon EY*:
Identification of recurrent regulated alternative splicing events across human solid tumors.
44. Knisbacher BA, Levanon EY:
DNA and RNA editing of retrotransposons accelerate mammalian genome evolution.
Annals of the New York Academy of Sciences 2015
43. Alon S, Garrett SC, Levanon EY, Olson S, Graveley BR, Rosenthal JJ, Eisenberg E:
The majority of transcripts in the squid nervous system are extensively recoded by A-to-I RNA editing.
2014
42. Liscovitch N, Bazak L, Levanon EY, Chechik G:
Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain.
41. Fang X*, Nevo E*, Han L*, Levanon EY*, Zhao J*, Avivi A*, Larkin D*, Jiang X*, Feranchuk S, Zhu Y, Fishman A, Feng Y, Sher N, Xiong Z, Hankeln T, Huang Z, Gorbunova V, Zhang L, Zhao W, Wildman DE, Xiong Y, Gudkov A, Zheng Q, Rechavi G, Liu S, Bazak L, Chen J, Knisbacher BA, Lu Y, Shams I, et al.:
Genome-wide adaptive complexes to underground stresses in blind mole rats Spalax.
40. Pinto Y, Cohen HY, Levanon EY:
Mammalian conserved ADAR targets comprise only a small fragment of the human editosome.
39. Bazak L, Haviv A, Barak M, Jacob-Hirsch J, Deng P, Zhang R, Isaacs FJ, Rechavi G, Li JB, Eisenberg E*, Levanon EY*:
A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes.
38. Porath HT, Carmi S, Levanon EY:
A genome-wide map of hyper-edited RNA reveals numerous new sites.
37. Bazak L, Levanon EY, Eisenberg E:
Genome-wide analysis of Alu editability.
36. Levanon EY, Eisenberg E:
Does RNA editing compensate for Alu invasion of the primate genome?
35. Solomon O, Bazak L, Levanon EY, Amariglio N, Unger R, Rechavi G, Eyal E:
Characterizing of functional human coding RNA editing from evolutionary, structural and dynamic perspectives.
Proteins: Structure, Function, and Bioinformatics 2014
34. Gal M, Levanon EY, Hujeirat Y, Khayat M, Pe’er J, Shalev S:
Novel mutation in TSPAN12 leads to autosomal recessive inheritance of congenital vitreoretinal disease with intra-familial phenotypic variability.
American Journal of Medical Genetics Part A 2014
2013
33. Lindič N, Budič M, Petan T, Knisbacher BA, Levanon EY, Lovšin N:
Differential inhibition of LINE1 and LINE2 retrotransposition by vertebrate AID/APOBEC proteins.
32. Eisenberg E, Levanon EY:
Human housekeeping genes, revisited.
2012
31. Sanjana NE, Levanon EY, Hueske EA, Ambrose JM, Li JB:
Activity-dependent A-to-I RNA editing in rat cortical neurons.
2011
30. Carmi S, Church GM, Levanon EY:
Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution.
29. Carmi S, Borukhov I, Levanon EY:
Identification of widespread ultra-edited human RNAs.
2010
28. Zaranek AW*, Levanon EY*, Zecharia T, Clegg T, Church GM:
A Survey of Genomic Traces Reveals a Common Sequencing Error, RNA Editing, and DNA Editing.
27. Paz-Yaacov N, Levanon EY, Nevo E, Kinar Y, Harmelin A, Jacob-Hirsch J, Amariglio N, Eisenberg E, Rechavi G:
Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates.
26. Nicholas A, de Magalhaes JP, Kraytsberg Y, Richfield EK, Levanon EY, Khrapko K:
Age-related gene-specific changes of A-to-I mRNA editing in the human brain.
Mechanisms of Ageing and Development 2010
25. Greenberger S*, Levanon EY*, Paz-Yaacov N, Barzilai A, Safran M, Osenberg S, Amariglio N, Rechavi G, Eisenberg E.
Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats.
24. Eisenberg E, Li JB, Levanon EY:
Sequence based identification of RNA editing sites.
2009
23. Carmi S, Levanon EY, Eisenberg E:
Efficiency of complex production in changing environment.
BMC Systems Biology 2009
22. Li JB*, Levanon EY*, Yoon J-K, Aach J, Xie B, Leproust E, Zhang K, Gao Y, Church GM:
Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing.
21. Barak M*, Levanon EY*, Eisenberg E, Paz N, Rechavi G, Church GM, Mehr R:
Evidence for large diversity in the human transcriptome created by Alu RNA editing.
2008
20. Lev-Maor G, Ram O, Kim E, Sela N, Goren A, Levanon EY, Ast G:
Intronic Alus influence alternative splicing.
2007
19. Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, Krupsky M, Ben-Dov I, Cazacu S, Mikkelsen T, Brodie C, Eisenberg E, Rechavi G:
Altered adenosine-to-inosine RNA editing in human cancer.
18. Lev-maor G, Sorek R, Levanon EY, Paz N, Eisenberg E, Ast G:
RNA-editing-mediated exon evolution.
2006
17. Neeman Y*, Levanon EY*, Jantsch MF, Eisenberg E:
RNA editing level in the mouse is determined by the genomic repeat repertoire.
16. Levanon EY, Eisenberg E:
Algorithmic approaches for identification of RNA editing sites.
Brief Functional Genomic Proteomic 2006
15. Carmi S, Levanon EY, Havlin S, Eisenberg E:
Connectivity and expression in protein networks: proteins in a complex are uniformly expressed.
2005
14. Neeman Y, Dahary D, Levanon EY, Sorek R, Eisenberg E:
Is there any sense in antisense editing?
13. Levanon K, Eisenberg E, Rechavi G, Levanon EY:
Letter from the editor: Adenosine-to-inosine RNA editing in Alu repeats in the human genome.
12. Levanon EY, Hallegger M, Kinar Y, Shemesh R, Djinovic-Carugo K, Rechavi G, Jantsch MF, Eisenberg E, Djinoviccarugo K:
Evolutionarily conserved human targets of adenosine to inosine RNA editing.
11. Kliger Y, Levanon EY, Gerber D:
From genome to antivirals: SARS as a test tube.
10. Havilio M, Levanon EY, Lerman G, Kupiec M, Eisenberg E:
Evidence for abundant transcription of non-coding regions in the Saccharomyces cerevisiae genome.
9. Eisenberg E, Nemzer S, Kinar Y, Sorek R, Rechavi G, Levanon EY:
Is abundant A-to-I RNA editing primate-specific?.
8. Eisenberg E, Adamsky K, Cohen L, Amariglio N, Hirshberg A, Rechavi G, Levanon EY:
Identification of RNA editing sites in the SNP database.
2004
7. Hazkani-Covo E, Levanon EY, Rotman G, Graur D, Novik A:
Evolution of multicellularity in Metazoa: comparative analysis of the subcellular localization of proteins in Saccharomyces, Drosophila and Caenorhabditis.
Cell Biology International 2004
6. Levanon EY*, Eisenberg E*, Yelin R*, Nemzer S*, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, Olshansky M, Rechavi G, Jantsch MF:
Systematic identification of abundant A-to-I editing sites in the human transcriptome.
2003
5. Levanon EY, Sorek R:
The importance of alternative splicing in the drug discovery process.
4. Kliger Y, Levanon EY:
Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.
3. Eisenberg E, Levanon EY:
Preferential attachment in the protein network evolution.
Widespread occurrence of antisense transcription in the human genome.
1. Eisenberg E, Levanon EY:
Human housekeeping genes are compact.